Health care companies by P/S ratio
Market value divided by the latest fiscal year's revenue: what the market pays for each dollar of sales.
Centene has the lowest figure of the 154 health care companies ranked by P/S ratio, at 0.2, followed by Cencora (0.2) and Molina Healthcare (0.2). Figures as of 19 Nov 2026, 21:24 UTC, from Yahoo Finance quotes.
Key facts
- Companies ranked
- 154
- Lowest
- Centene0.2
- Median
- 4.2
- Combined market value
- DKK 60.79T
- Countries
- 14
- Not ranked
- 16no P/S ratio on file
Market values as of .
All countries▾
Health Care▾
All categories▾
| # | Company | P/S ↑ | Market cap | Price | Today | 1 year | Price, 30 days | Country |
|---|---|---|---|---|---|---|---|---|
| 101 | IlluminaILMN · Health Care | 7.0 | DKK 206.7B | DKK 1,367.37 | 4.45% down | 76% up | ||
| 102 | Medpace HoldingsMEDP · Health Care | 7.0 | DKK 120.8B | DKK 4,320.28 | 1.99% down | 10% up | ||
| 103 | Gilead SciencesGILD · Health Care | 7.0 | DKK 1.41T | DKK 1,134.82 | 1.45% down | 35% up | ||
| 104 | Agilent TechnologiesA · Health Care | 7.1 | DKK 336.9B | DKK 1,194.86 | 1.12% down | 22% up | ||
| 105 | Arrowhead PharmaceuticalsARWR · Health Care | 7.4 | DKK 42.1B | DKK 297.45 | 1.25% up | 13% up | ||
| 106 | United TherapeuticsUTHR · Health Care | 7.5 | DKK 162.3B | DKK 3,810.00 | 3.16% down | 22% up | ||
| 107 | Halozyme TherapeuticsHALO · Health Care | 7.6 | DKK 72.3B | DKK 634.02 | 2.88% down | 39% up | ||
| 108 | AbbVieABBV · Health Care | 8.2 | DKK 3.42T | DKK 1,932.19 | 0.86% down | 25% up | ||
| 109 | Mettler-Toledo InternationalMTD · Health Care | 8.4 | DKK 231.2B | DKK 11,623.27 | 1.82% down | 24% up | ||
| 110 | GenmabGMAB · Health Care | 8.5 | DKK 215.8B | DKK 349.93 | 0.75% up | 70% up | ||
| 111 | BeOne MedicinesONC · Health Care | 8.5 | DKK 311.1B | DKK 2,723.77 | 0.97% down | 16% up | ||
| 112 | PenumbraPEN · Health Care | 9.0 | DKK 86B | DKK 2,180.72 | 0.18% down | 15% up | ||
| 113 | West Pharmaceutical ServicesWST · Health Care | 9.0 | DKK 188.3B | DKK 2,703.26 | 1.81% down | 57% up | ||
| 114 | Corcept TherapeuticsCORT · Health Care | 9.3 | DKK 48.5B | DKK 442.81 | 4.15% down | 10% down | ||
| 115 | Bio-TechneTECH · Health Care | 9.4 | DKK 77.8B | DKK 495.42 | 0.07% down | 24% up | ||
| 116 | Travere TherapeuticsTVTX · Health Care | 9.4 | DKK 31.6B | DKK 329.14 | 3.86% down | 45% up | ||
| 117 | Madrigal PharmaceuticalsMDGL · Health Care | 9.6 | DKK 62.8B | DKK 2,703.60 | 0.34% down | 27% down | ||
| 118 | Edwards LifesciencesEW · Health Care | 9.8 | DKK 407B | DKK 707.89 | 1.28% down | 25% up | ||
| 119 | Kiniksa Pharmaceuticals InternationalKNSA · Health Care | 10.8 | DKK 50.1B | DKK 637.40 | 1.59% down | 129% up | ||
| 120 | Vertex PharmaceuticalsVRTX · Health Care | 11.0 | DKK 899.6B | DKK 3,548.05 | 2.94% down | 27% up | ||
| 121 | Axsome TherapeuticsAXSM · Health Care | 11.2 | DKK 48.6B | DKK 924.60 | 1.25% up | 6% down | ||
| 122 | 10x GenomicsTXG · Health Care | 11.7 | DKK 51.4B | DKK 391.02 | 0.54% up | 247% up | ||
| 123 | Mirum PharmaceuticalsMIRM · Health Care | 12.0 | DKK 42.5B | DKK 650.86 | 3.27% up | 34% up | ||
| 124 | IDEXX LaboratoriesIDXX · Health Care | 12.6 | DKK 370.3B | DKK 4,699.64 | 1.26% down | 1% up | ||
| 125 | Intuitive SurgicalISRG · Health Care | 14.0 | DKK 962B | DKK 2,775.15 | 3.26% down | 24% down | ||
| 126 | BillionToOneBLLN · Health Care | 14.1 | DKK 29.4B | DKK 614.67 | 1.46% down | 4% down | ||
| 127 | argenxARGX · Health Care | 14.3 | DKK 403.7B | DKK 6,419.56 | 0.08% up | 2% up | ||
| 128 | RepligenRGEN · Health Care | 14.7 | DKK 74.2B | DKK 1,160.45 | 1.38% down | 12% up | ||
| 129 | TG TherapeuticsTGTX · Health Care | 15.9 | DKK 66.8B | DKK 442.13 | 1.88% down | 117% up | ||
| 130 | Royalty PharmaRPRX · Health Care | 16.4 | DKK 265.3B | DKK 461.48 | 1.38% down | 79% up | ||
| 131 | Adaptive BiotechnologiesADPT · Health Care | 16.4 | DKK 30.9B | DKK 191.15 | 1.44% down | 74% up | ||
| 132 | NateraNTRA · Health Care | 18.2 | DKK 286.5B | DKK 1,975.67 | 0.15% up | 28% up | ||
| 133 | Eli LillyLLY · Health Care | 18.5 | DKK 8.2T | DKK 9,207.25 | 2.29% down | 33% up | ||
| 134 | Guardant HealthGH · Health Care | 20.1 | DKK 134.2B | DKK 992.13 | 0.31% up | 45% up | ||
| 135 | Twist BioscienceTWST · Health Care | 20.2 | DKK 51.9B | DKK 760.64 | 4.07% down | 346% up | ||
| 136 | Ascendis PharmaASND · Health Care | 21.0 | DKK 114.4B | DKK 1,744.25 | 5.32% down | 29% up | ||
| 137 | Ligand PharmaceuticalsLGND · Health Care | 21.4 | DKK 39.1B | DKK 1,955.36 | 3.94% down | 50% up | ||
| 138 | HeartflowHTFL · Health Care | 22.3 | DKK 26.7B | DKK 304.13 | 2.75% down | 66% up | ||
| 139 | Krystal BiotechKRYS · Health Care | 24.1 | DKK 63.8B | DKK 2,152.16 | 0.15% up | 54% up | ||
| 140 | GlaukosGKOS · Health Care | 27.8 | DKK 96B | DKK 1,622.54 | 2.15% up | 145% up | ||
| 141 | WatersWAT · Health Care | 28.3 | DKK 611.4B | DKK 3,110.70 | 2.06% down | 23% up | ||
| 142 | BridgeBio PharmaBBIO · Health Care | 30.3 | DKK 103.8B | DKK 532.76 | 0.22% up | 21% up | ||
| 143 | GRAILGRAL · Health Care | 32.0 | DKK 32.1B | DKK 714.44 | 2.68% up | 19% up | ||
| 144 | ModernaMRNA · Health Care | 41.5 | DKK 549.6B | DKK 1,358.34 | 1.29% up | 780% up | ||
| 145 | Rhythm PharmaceuticalsRYTM · Health Care | 42.7 | DKK 55.2B | DKK 795.94 | 1.88% down | 18% up | ||
| 146 | InsmedINSM · Health Care | 52.3 | DKK 216B | DKK 984.43 | 20.58% up | 40% down | ||
| 147 | ImmunityBioIBRX · Health Care | 61.7 | DKK 47.6B | DKK 44.77 | 1.94% down | 232% up | ||
| 148 | CytokineticsCYTK · Health Care | 81.4 | DKK 48.9B | DKK 350.68 | 0.27% up | 19% down | ||
| 149 | Protagonist TherapeuticsPTGX · Health Care | 176 | DKK 55.2B | DKK 845.14 | 2.47% down | 51% up | ||
| 150 | Kymera TherapeuticsKYMR · Health Care | 260 | DKK 69.5B | DKK 813.59 | 1.44% down | 87% up | ||
| 151 | CRISPR TherapeuticsCRSP · Health Care | 1076 | DKK 25.7B | DKK 265.29 | 3.14% down | 18% down | ||
| 152 | CG OncologyCGON · Health Care | 1811 | DKK 49.8B | DKK 558.11 | 2.38% up | 97% up | ||
| 153 | Dianthus TherapeuticsDNTH · Health Care | 2346 | DKK 32.6B | DKK 578.08 | 1.01% up | 108% up | ||
| 154 | Roivant SciencesROIV · Health Care | 3418 | DKK 192.4B | DKK 265.49 | 0.59% up | 91% up |
Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration.
Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. P/S divides today's market value by the latest fiscal year's revenue from the annual report. Sums are converted from US dollars at today's exchange rate (1 USD = 6.8145 DKK). 16 companies have no P/S ratio on file and are not ranked here.
Questions and answers
Which health care companies have the lowest P/S ratio?
Centene (0.2), Cencora (0.2) and Molina Healthcare (0.2) have the lowest P/S ratio of the 154 health care companies ranked here as of 19 Nov 2026, 21:24 UTC.
How many health care companies are in this ranking?
154 are ranked by P/S ratio. 16 more have no P/S ratio on file and are left out rather than ranked at zero.
What are these health care companies worth together?
The 154 health care companies ranked by P/S ratio have a combined market value of DKK 60.79T as of 19 Nov 2026, 21:24 UTC.
What does ranking by P/S ratio measure?
Market value divided by the latest fiscal year's revenue: what the market pays for each dollar of sales.
Learn how this ranking works
All markets guides →- P/E ratio explained: what a high or low figure means
The price-to-earnings (P/E) ratio is a share's price divided by its earnings per share. A stock at $100 earning $5 a share has a P/E of 20: buyers pay $20 for each dollar of yearly profit. A high P/E usually means the market expects profit to grow; a low one can mean doubt, not a bargain.
- Revenue vs earnings vs free cash flow: what each tells you
Revenue is everything a company sold in a period. Earnings, or net income, is what remains after every cost, interest and tax. Free cash flow is the cash operations brought in minus spending on long-lived assets. Revenue shows size and demand, earnings show profitability, and free cash flow shows how much cash the business can actually hand out.
- How an ETF's size is measured: AUM, NAV and creation units
An ETF's size is usually measured by its assets under management (AUM), the fund's net assets: everything it holds minus what it owes. That equals net asset value per share times shares outstanding. AUM grows when the holdings rise in value and when large institutions create new shares, and shrinks when they redeem them.
Cite this page
Funkfolio, “Health care companies by P/S ratio”, data as of 19 November 2026. https://funkfolio.com/companies/sector/health-care?by=ps-ratio
Underlying data: Yahoo Finance; SEC EDGAR.